Molecular & Cellular Biology
Gluten sensitivity and the incidence of Celiac disease are ever increasing. The aim was to measure the effectiveness of an enzyme based dietary supplement on the reduction of symptoms encountered upon the consumption of gluten.
The data showed a statistically significant improvement when compared to the placebo group in the following categories: pain, bloating, emptying of bowels, hunger pains, rumbling of stomach, lower energy levels, headaches, and food cravings. There was no statistically signficant improvement in the following symptoms: comfort, nausea, and loss of appetite.
Overall, the dietary supplement, Glutalytic, reduced many of the symptoms that are encountered upon the consumption of gluten.
Hudson, M., & King, C. Glutalytic Clinical Trial for Normal Consumption of Gluten Containing Foods.